The participation will allow specialists of the leading national pharmaceutical manufacturer to improve the competencies necessary for the production of drugs based on RNA technology. The project is implemented within…
Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Roughly a year after disclosing plans to…